• First placental membrane allograft to preserve all three native layers of the tissue: the amnion, the intermediate layer, and the chorion
• Proprietary processing method, Clearify, delivers an optimized tissue allograft which preserves more of the native 3D architecture and components than the previous generation of amniotic tissue allografts
• The retained intermediate layer contains key components like hyaluronic acid and a variety of collagens

Revita® is to be used as a wound covering, or barrier membrane, over chronic and acute wounds, including dermal ulcers or defects.

Do not use Revita® on any wound with evidence of active, latent infection or gangrene.
Do not use Revita® on compromised patients where the patient's condition may create an unacceptable risk of post-operative infection or complications.

Revita® is for single patient use only. Do not sterilize or re-sterilize. Wounds treated with Revita® should be monitored for signs of infection and treated according to standard practice should infection occur post-transplantation.
Store at ambient temperature. Keep away from excessive heat. Do not freeze.

No current adverse effects or reactions attributed to the Revita® allograft.

The Revita® allograft should be maintained in its original packaging and stored at ambient temperature (0°C-38°C) until ready for use. When stored properly in their original packaging, Revita® allografts are shelf-stable for up to five years.